Duality Advisers’s Medifast MED Stock Holding History

Duality Advisers’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,227	Closed	-$297K	–	655
2023 Q2	$297K	Sell	3,227 -1,425	-31%	-$127K	0.04%	450
2023 Q1	$482K	Buy	+4,652	New	+$516K	0.05%	417

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Duality Advisers's MED Position: Q3 2023 in Review

Duality Advisers sold out of Medifast (MED) in Q3 2023, closing a stake of 3,227 shares — an estimated $297K sold.

Duality Advisers first reported a position in MED in Q1 2023 and held it in 2 quarters. The position peaked at $482K in Q1 2023. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

Duality Advisers reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
Duality Advisers sold 3,227 Medifast shares in Q3 2023, an estimated $297K.
Duality Advisers first reported a position in Medifast in Q1 2023 and held it in 2 quarters.
Duality Advisers's Medifast position peaked at $482K in Q1 2023.
223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on Duality Advisers's 13F filing for Q3 2023, filed 2 Nov 2023.